<- Go Home

Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Market Cap

EUR 2.5B

Volume

3.8K

Cash and Equivalents

EUR 149.6M

EBITDA

EUR 272.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 941.3M

Profit Margin

67.36%

52 Week High

EUR 400.00

52 Week Low

EUR 289.50

Dividend

0.49%

Price / Book Value

2.36

Price / Earnings

16.93

Price / Tangible Book Value

4.77

Enterprise Value

EUR 2.6B

Enterprise Value / EBITDA

9.17

Operating Income

EUR 226.6M

Return on Equity

14.93%

Return on Assets

8.57

Cash and Short Term Investments

EUR 153.9M

Debt

EUR 312.8M

Equity

EUR 1.0B

Revenue

EUR 1.4B

Unlevered FCF

EUR 75.9M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches